Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.

Cancer cell | 2019

Androgen deprivation therapy for prostate cancer (PCa) benefits patients with early disease, but becomes ineffective as PCa progresses to a castration-resistant state (CRPC). Initially CRPC remains dependent on androgen receptor (AR) signaling, often through increased expression of full-length AR (ARfl) or expression of dominantly active splice variants such as ARv7. We show in ARv7-dependent CRPC models that ARv7 binds together with ARfl to repress transcription of a set of growth-suppressive genes. Expression of the ARv7-repressed targets and ARv7 protein expression are negatively correlated and predicts for outcome in PCa patients. Our results provide insights into the role of ARv7 in CRPC and define a set of potential biomarkers for tumors dependent on ARv7.

Pubmed ID: 30773341 RIS Download

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: P50 CA090381
  • Agency: NCI NIH HHS, United States
    Id: P50 CA097186
  • Agency: BLRD VA, United States
    Id: I01 BX003324
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK007529
  • Agency: BLRD VA, United States
    Id: I01 BX000585
  • Agency: NHGRI NIH HHS, United States
    Id: R01 HG008927
  • Agency: NCI NIH HHS, United States
    Id: P01 CA163227

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


NCOR2 antibody - ChIP Grade (antibody)

RRID:AB_2149134

This polyclonal targets NCOR2

View all literature mentions

FOXA1 antibody - ChIP Grade (antibody)

RRID:AB_304744

This polyclonal targets FOXA1 antibody - ChIP Grade

View all literature mentions

AR (C-19) (antibody)

RRID:AB_630864

This polyclonal targets AR

View all literature mentions

H3K27ac polyclonal antibody (antibody)

RRID:AB_2637079

This polyclonal targets H3K27ac

View all literature mentions

Androgen Receptor (antibody)

RRID:AB_626671

This monoclonal targets Raised against amino acids 299-315 of AR of human origin.

View all literature mentions

FOXA1 antibody - ChIP Grade (antibody)

RRID:AB_2104842

This polyclonal targets Foxa1

View all literature mentions

Androgen Receptor (antibody)

RRID:AB_1563391

This unknown targets ND

View all literature mentions

NCoR1 Polyclonal Antibody (antibody)

RRID:AB_2149004

This unknown targets NCoR1

View all literature mentions

Androgen Receptor (antibody)

RRID:AB_626671

This monoclonal targets Raised against amino acids 299-315 of AR of human origin.

View all literature mentions

NCoR1 Polyclonal Antibody (antibody)

RRID:AB_2149004

This unknown targets NCoR1

View all literature mentions

AR (C-19) (antibody)

RRID:AB_630864

This polyclonal targets AR

View all literature mentions

Androgen Receptor (antibody)

RRID:AB_1563391

This unknown targets ND

View all literature mentions

FOXA1 antibody - ChIP Grade (antibody)

RRID:AB_304744

This polyclonal targets FOXA1 antibody - ChIP Grade

View all literature mentions

H3K27ac polyclonal antibody (antibody)

RRID:AB_2637079

This polyclonal targets H3K27ac

View all literature mentions

FOXA1 antibody - ChIP Grade (antibody)

RRID:AB_2104842

This polyclonal targets Foxa1

View all literature mentions

NCOR2 antibody - ChIP Grade (antibody)

RRID:AB_2149134

This polyclonal targets NCOR2

View all literature mentions